India Health Ministry Says Roche A No-Show To Defend Patent Challenge
This article was originally published in PharmAsia News
Executive Summary
India's health ministry says say Roche lost divisional patents for its Herceptin (trastuzumab) breast-cancer drug because it failed to respond in a timely manner to a post-grant challenge.